Elevation Series Trust (CIK 0001936157)

Price not priced yet ⚠ · Not investment advice

Elevation Series Trust (CIK 0001936157)

ONEZ SEC NPORT-P
ETF X-ray
Holdings15
Analyzed0 / 15
% Money-losing by weight0.0%

Most doctors who buy ONEZ don't know what they own. Here's a snapshot of what the constituents look like through SAVNG's lens.

VERY STALE Holdings as of May 28, 2026 (134 days ago). Over 100 days old — re-fetch from the issuer before using for any decision.

ETF holdings change continuously and our snapshot reflects the most recent disclosure available — typically 1-30 days old for major issuers (iShares, Vanguard, State Street publish daily-to-weekly) or 30-90 days old for funds where we rely on SEC Form NPORT-P (quarterly, with up to 60-day filing lag). Do not use this list to make tax-lot or timing decisions.

Top constituents by weight

TickerNameCUSIPWeightP/IVEPS TTM
QBER TrueShares Quarterly Bear Hedg 210322509 10.22% — —
JULZ Trueshares Structured Outcome 210322822 8.03% — —
FEBZ Elevation Series Trust - Trues 210322871 7.85% — —
DECZ Elevation Series Trust - Trues 210322764 7.65% — —
JANZ Elevation Series Trust - Trues 210322681 7.47% — —
MARZ Elevation Series Trust - Trues 210322863 7.31% — —
JUNZ Elevation Series Trust - TrueS 210322830 7.13% — —
AUGZ Trueshares Structured Outcome 210322814 7.12% — —
APRZ Elevation Series Trust - Trues 210322855 6.94% — —
SEPZ Elevation Series Trust - Trues 210322798 6.74% — —
OCTZ Elevation Series Trust - Trues 210322780 6.54% — —
MAYZ Elevation Series Trust - Trues 210322848 6.40% — —
NOVZ Elevation Series Trust - Trues 210322772 6.21% — —
QBUL TrueShares Quarterly Bull Hedg 210322400 4.23% — —
SALXX STATE STREET INSTITUTIONAL US 857492656 0.19% — —

Showing top 25 of 15 by weight. 15 rows lack a ticker — NPORT-P filings only carry CUSIPs, not tickers. Click the CUSIP to look it up on SEC EDGAR. P/IV and EPS shown only for constituents we've analyzed. Sourced from SEC NPORT-P public holdings disclosure.

⚠️ Not investment advice. ETF holdings change continuously. The constituent-level analyses use SAVNG's stock-page methodology and inherit all of its limitations. See the full disclaimer.